Please Wait
Applying Filters...
menu
    • menu
    SPI Pharma has been solving formulation challenges using superior functional materials.

    Virtual Booth

    Contact Supplier

    As a CDMO, Mikart offers integrated CDMO services for Solid Dose & Non-sterile Liquid formulations.

    Virtual Booth

    Contact Supplier

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    End-to-end drug development, specializing in high-potency softgels and liquids, providing global partners with a competitive advantage.

    Virtual Booth

    Contact Supplier

    Minakem delivers API, HPAPI, steroids & CDMO services for generics with FDA/GMP certification, regulatory know-how & proven success.

    Virtual Booth

    Contact Supplier

    jdmfs-not-supported-m-2025-06-23

    Virtual Booth

    An Enquiry

    Menu

    Radiprodil

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass
    $ API Ref.Price (USD/KG) : 148,589Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Epilepsy Biotech Nabs up to $570M in Deal With Angelini
    Epilepsy Biotech Nabs up to $570M in Deal With Angelini

    28 May 2025

    // BIOSPACW

    https://www.biospace.com/deals/epilepsy-biotech-nabs-up-to-570m-in-deal-with-italys-angelini-plus-140m-fundraising

    BIOSPACW
    28 May 2025
    Share Share
    GRIN Therapeutics Gets EU Orphan Designation for Radiprodil
    GRIN Therapeutics Gets EU Orphan Designation for Radiprodil

    06 May 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/grin-therapeutics-receives-positive-opinion-for-eu-orphan-designation-for-radiprodil-for-treatment-of-grin-related-neurodevelopmental-disorder-302446917.html

    PR NEWSWIRE
    06 May 2025
    Share Share
    GRIN Therapeutics Receives PRIME Designation from EMA for Radiprodil
    GRIN Therapeutics Receives PRIME Designation from EMA for Radiprodil

    01 Apr 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/grin-therapeutics-receives-priority-medicines-prime-designation-from-ema-for-radiprodil-in-the-treatment-of-grin-related-neurodevelopmental-disorder-302416531.html

    PR NEWSWIRE
    01 Apr 2025
    Share Share
    GRIN Therapeutics gets FDA Orphan Drug Designation for Radiprodil
    GRIN Therapeutics gets FDA Orphan Drug Designation for Radiprodil

    17 Mar 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/grin-therapeutics-receives-fda-orphan-drug-designation-for-radiprodil-for-the-treatment-of-grin-related-neurodevelopmental-disorder-302402623.html

    PR NEWSWIRE
    17 Mar 2025
    Share Share
    GRIN Therapeutics gets FDA Breakthrough Therapy for Radiprodil
    GRIN Therapeutics gets FDA Breakthrough Therapy for Radiprodil

    25 Feb 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/grin-therapeutics-receives-fda-breakthrough-therapy-designation-for-radiprodil-302384417.html

    PR NEWSWIRE
    25 Feb 2025
    Share Share
    GRIN Therapeutics Presents Honeycomb Trial Data of Radiprodil
    GRIN Therapeutics Presents Honeycomb Trial Data of Radiprodil

    09 Dec 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/grin-therapeutics-presents-data-from-honeycomb-trial-of-radiprodil-at-the-american-epilepsy-society-annual-meeting-302324666.html

    PR NEWSWIRE
    09 Dec 2024
    Share Share